Rejuvel Bio-Sciences, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NUUU research report →
Price Chart
About the company
Rejuvel Bio-Sciences, Inc. is a development-stage firm operating globally, primarily involved in the production, distribution, and marketing of skincare products. Its main offering is a skin cream sold under the Rejuvel brand.
- CEO
- Charles J. Scimeca
- IPO
- 2014
- Employees
- 1
- HQ
- Miami, FL, US
Get TickerSpark's AI analysis on NUUU
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $117.77K
- P/E
- -0.03
- PEG
- 0.00
- P/S
- 1.25
- P/B
- -0.01
- EV/EBITDA
- -0.95
- Div Yield
- 0.00%
- Gross Margin
- 11.47%
- Op Margin
- -730.32%
- Net Margin
- -375.01%
- ROE
- 36.48%
- ROIC
- 101.60%
Latest fiscal year · YoY change
- Revenue
- $94.10K+82.5%
- Gross Profit
- $10.79K-56.4%
- Op Income
- $-687,205
- Net Income
- $-352,865+50.7%
- EPS
- $-0.00+63.0%
- OCF Growth
- -65.7%
- FCF Growth
- -71.2%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.88
- RSI (14)
- 44
- Avg Volume
- 336.02K
No earnings-call transcripts are available for NUUU yet.
- Free Float
- 69.8%
- Shares Outstanding
- 1.18B
- Float Shares
- 822.46M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 19, 17 | PAVLIK JOSEPH | other | 0 |
| Jan 19, 17 | PAVLIK JOSEPH | other | 0 |
| Jan 19, 17 | SCIMECA CHARLES J | other | 0 |
| Jan 19, 17 | SCIMECA CHARLES J | other | 0 |
| Nov 1, 16 | SCIMECA CHARLES J | buy | 330,000,000 |
| Sep 28, 16 | SCIMECA CHARLES J | buy | 6,896,552 |
| Sep 28, 16 | SCIMECA CHARLES J | buy | 17,253 |
| Apr 18, 16 | SCIMECA CHARLES J | sell | 2,468,000 |
| Mar 2, 16 | SCIMECA CHARLES J | sell | 4,675,000 |
| Feb 26, 16 | SCIMECA CHARLES J | buy | 111,607 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our NUUU coverage
Recent articles, reports, and earnings notes.
No research on NUUU yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NUUU report →Head to Head Contrast: Rejuvel Bio-Sciences (OTCMKTS:NUUU) & Helen of Troy (NASDAQ:HELE)
defenseworld.net · Mar 23
Reviewing Solesence (NASDAQ:SLSN) and Rejuvel Bio-Sciences (OTCMKTS:NUUU)
defenseworld.net · Mar 5
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.